Alerte De Sécurité sur Fortify ST Implantable cardioverter defibrillator

Selon Department of Health, ce/cet/cette alerte de sécurité concerne un dispositif en/au/aux/à Hong Kong qui a été fabriqué par St Jude Medical.

Qu'est-ce que c'est?

Les alertes fournissent des informations importantes et des recommandations concernant les dispositifs médicaux. Le fait qu'une alerte soit émise ne signifie pas nécessairement qu'un dispositif soit dangereux. Les alertes de sécurité, qui sont envoyées tant aux travailleurs du secteur médical qu'aux utilisateurs de ces dispositifs, peuvent inclure des rappels. Elles peuvent être rédigées par des fabricants mais aussi par des autorités en charge de la santé.

En savoir plus sur les données ici
  • Type d'événement
    Safety alert
  • Date
  • Date de publication de l'événement
  • Pays de l'événement
  • Source de l'événement
  • URL de la source de l'événement
  • Notes / Alertes
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • Notes supplémentaires dans les données
    Medical Device Safety Alert
  • Cause
    Medical device safety alert: st jude medical fortify st implantable cardioverter defibrillator the medicines and healthcare products regulatory agency (mhra), united kingdom posted a medical device safety alert concerning fortify st implantable cardioverter defibrillator (icd) models [cd1235-40, cd1235-40q, cd2235-40 and cd2235-40q], manufactured by st jude medical. the merlin pcs programmer software model 3330 versions 14.2.2, 16.2.1 and provide new features for st. jude medical pacemakers, icds and crt-ds, including an option to enhance the st diagnostic features in st. jude medical fortify st icd models cd1235-40, cd1235-40q, cd2235-40 and cd2235-40q via a device software upgrade. during a device software upgrade, implanted devices are temporarily placed into the back-up pacing (bvvi) and back-up defibrillation only (bdfo) mode. the back-up mode parameter settings will be in effect for the two minute upgrade process. once the upgrade successfully completes, the device will revert to the previously programmed parameter settings. the safety alert is being provided to ensure that the operation of these devices during backup operation is clearly understood. depending on the individual patient, this temporary change in parameter values could make the device susceptible to over-sensing and potentially deliver high voltage therapy during the upgrade procedure. in order to prevent the potential for inappropriate therapy during the software upgrade process, the manufacturer advises users to consider programming the “tachy therapy enabled/disabled” function to disabled prior to proceeding with the software upgrade. it is imperative to re-interrogate the device and program the “tachy therapy enabled/disabled” function to enabled after the upgrade has been successfully completed. as with any device evaluation and programming, ecg monitoring and availability of back up external defibrillation equipment is recommended during the entire software upgrade process. according to the local supplier, the affected products were distributed in hong kong. for details, please visit the following mhra website: http://www.Mhra.Gov.Uk/safetyinformation/safetywarningsalertsandrecalls/ fieldsafetynotices/con261823 if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 23 april 2013.


  • Modèle / numéro de série
  • Description du dispositif
    Medical Device Safety Alert: St Jude Medical Fortify ST Implantable cardioverter defibrillator
  • Manufacturer


  • Société-mère du fabricant (2017)
  • Commentaire du fabricant
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source